Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05424354

Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing

This study is being performed to assess the effectiveness of Altrazeal(R) Transforming Powder Dressing (TPD) in patients with partial thickness burns compared to the current standard of care (SOC) dressing. Adult men and women 18-65 years old who are hospitalized with an acute (meaning the burn injury occurred less than 72 hours prior to enrollment in the study) partial thickness burn wound, less than 20 percent of total body surface area may be considered. Subjects will be randomized in a 1:1 ratio to either SOC or TPD. Subjects will be followed for up to 28 days after enrollment.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

University of California-Irvine, Orange, California, United States

Loading trial locations.

About this study

This post-marketing study is being performed to assess the effectiveness of Altrazeal(R) Transforming Powder Dressing (TPD) in patients with partial thickness burns compared to the current standard of care (SOC) dressing for burn wounds. Adult men and women 18-65 years old who are hospitalized with an acute (meaning the burn injury occurred less than 36 hours prior to enrollment in the study) partial thickness burn wound, comprising less than 20 percent of total body surface area may be considered. Subjects will be randomized in a 1:1 ratio to either SOC or TPD. Subjects will be followed during hospitalization and then upon discharge from the hospital for up to 28 days after enrollment into the study. At each of the 8 study visits, the burn wound will be evaluated, photographed and measured. The wound will be cleaned and debrided, if needed, per usual standard burn care. A wound dressing will be applied using TPD or a typical SOC dressing. Wound healing and wound pain will be monitored at each visit, and the results of the two groups (TPD and SOC) will be compared to each other. A survey evaluating the satisfaction with the dressing received will be given at the end of the study, or when the wound heals, whichever comes first.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hospitalized patients who are receiving burn care; patients may be discharged when clinically stable and continue with outpatient treatment.
  • Men and women (women cannot be pregnant or breast feeding) ages 18-65 years old
  • Wounds must be partial thickness, involving up to 20% of the total body surface area.
  • Burn injury should be less than 72 hours old
  • Willing and able to comply with protocol mandated scheduled study visits/clinical evaluations.
  • Willing and able to provide written informed consent.

Exclusion criteria

  • Known allergy to TPD or its components
  • Women who are pregnant, breast feeding, or plan to get pregnant during the study period.
  • Infected wounds
  • Presence of any full thickness (third degree) burns
  • Electrical burns
  • Heavily draining burns due to underlying chronic lymphedema or other conditions
  • Concurrent clinical condition within the judgement of the clinician, pose a health risk to the patient, delay wound healing, or otherwise influence the outcome of the study.
  • History of poor wound healing and/or skin/immune system condition
  • Deemed by clinician not to be suitable
  • Unwilling or not able to provide consent or comply with protocol or required visits
  • Developmental disability/significant psychological disorder which can impair the subjects ability to provide informed consent, or participate in the study protocol
  • Active alcohol or substance abuse

Treatment and study plan

Altrazeal (R) Transforming Powder Dressing

Device

After informed consent and the subject is determined to meet all selection criteria, randomization will occur in a 1:1 ratio, to determine the treatment arm of the study. Half of those randomized will receive burn care with Altrazeal TPD.

Standard of Care burn dressing

Other

After informed consent and the subject is determined to meet all selection criteria, randomization will occur in a 1:1 ratio, to determine the treatment arm of the study. Half of those randomized will receive burn care with the institution's standard of care burn dressing.

Primary outcomes

  1. Pain from the Burn Wound

    Time frame: 28 days (or sooner if the wound heals prior to 28 days)

    Subjects will complete a visual analogue scale (VAS) to rate their pain prior to, during and after dressing changes. The scale ranges from 0 to 10, with 0 indicating no pain and 10 indicating the worst pain possible.

Secondary outcomes

  1. Wound healing

    Time frame: 28 days (or sooner if the wound heals prior to 28 days)

    Wounds will measured at each study visit to determine surface area healing.

  2. Safety of the Interventions (TPD and SOC)

    Time frame: 28 days (or sooner if the wound heals prior to 28 days)

    Complications such as infection, and other adverse events that develop will be documented, evaluated for severity, and compared between intervention groups.

  3. Subject satisfaction

    Time frame: End of Study

    Subjects will be asked to complete a subject satisfaction survey, which consists of 8 multiple choice questions regarding their wound dressing.

Study contacts

Contact information is provided by the study sponsor or research team.

Susan St John, MSN

CONTACT

[email protected]

4123035379

Vai Shah

CONTACT

[email protected]

2149055145

Sponsors and collaborators

Lead sponsor

ULURU Inc.

Industry

Collaborators

  • Navy Advanced Medical Development (NAMD) Command

Registry information

Official study title

Prospective Randomized Open Label Multicenter Phase IV Clinical Trial to Compare Transforming Powder Dressing (TPD) to Current Standard of Care (SOC) Dressing Therapies in Acute Partial Thickness Burn Wounds

Important dates

Study start
2022
Primary completion
2026
Study completion
2026
First posted
Jun 21, 2022
Registry last updated
Nov 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.